• AI-10-49: Precision CBFβ-SMMHC Inhibitor for AML Research

  2026-06-16

  AI-10-49 stands out as a precision tool for dissecting leukemogenic mechanisms in acute myeloid leukemia, selectively targeting the CBFβ-SMMHC fusion oncoprotein. This guide distills robust workflows, advanced applications, and optimization strategies to accelerate translational leukemia research using APExBIO’s validated inhibitor.

• USP7 Controls Macrophage Polarization via PKM2 in Pancreatit

  2026-06-15

  This study reveals that ubiquitin-specific protease 7 (USP7) drives pro-inflammatory macrophage polarization in severe acute pancreatitis (SAP) by modulating pyruvate kinase M2 (PKM2)-mediated metabolic reprogramming. Targeting the USP7–PKM2 axis uncovers new therapeutic avenues for controlling inflammation in SAP and informs future studies on immunometabolic interventions.

• Transcription-Independent Apoptosis: TNF-alpha’s Strategic F

  2026-06-15

  Translational researchers are rethinking apoptosis and inflammation models in light of new evidence that cell death can be triggered independently of gene transcription. This thought-leadership article explores how TNF-alpha recombinant murine protein is transforming the mechanistic and strategic landscape, integrating cutting-edge findings on transcription-independent apoptosis with actionable protocol guidance and a clear view of the translational horizon.

• CCCP in Precision Mitochondrial Morphology Assays: New Front

  2026-06-14

  Discover how CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is revolutionizing live-cell mitochondrial morphology assays, enabling advanced insights into neurodegenerative disease mechanisms. Explore distinct, evidence-based protocols, critical reference findings, and APExBIO’s unique research-grade advantages.

• SB 431542: Precision ALK5 Inhibition for Translational Impac

  2026-06-13

  SB 431542, a selective ALK5 inhibitor, is redefining the boundaries of TGF-β pathway research by enabling reproducible, mechanistically informed studies across oncology, immunology, and regenerative medicine. This article unites mechanistic insight with actionable guidance, highlighting how SB 431542 empowers translational researchers to interrogate TGF-β/Smad2 signaling with confidence, rigor, and strategic foresight.

• Homoharringtonine Rapidly Clears SARS-CoV-2: Reference Study

  2026-06-12

  A recent study demonstrates that homoharringtonine, a cytotoxic alkaloid, can eliminate SARS-CoV-2 from the upper respiratory tract within days, offering a possible first-line defense for future coronavirus outbreaks. This article examines the molecular rationale, translational data, and limitations of these findings for researchers in antiviral and cancer biology.

• Minoxidil Sulphate in Vascular and Hair Growth Research Work

  2026-06-12

  Minoxidil sulphate, the active metabolite of minoxidil, unlocks advanced modeling of vasodilation pathways and hair follicle dynamics in the lab. This guide delivers protocol enhancements, troubleshooting, and actionable insights to maximize reproducibility using APExBIO’s high-purity compound.

• Demethyleneberberine: Neuroprotective and Multi-Pathway Inno

  2026-06-11

  Explore the scientific basis and unique neuroprotective mechanisms of Demethyleneberberine (DMB), a natural isoquinoline alkaloid, in advanced disease modeling. This article uncovers DMB’s translational value for neurodegenerative and inflammatory research, with protocol guidance and mechanistic insight.

• CBD Attenuates Orofacial Inflammatory Pain via Endocannabino

  2026-06-11

  This study demonstrates that cannabidiol (CBD) effectively reduces both sensory and affective components of orofacial inflammatory pain in mice, highlighting the coordinated modulation of endocannabinoid and serotonergic systems. The findings provide mechanistic insight and support CBD's translational potential for multidimensional pain management strategies.

• Oseltamivir Acid: Influenza Neuraminidase Inhibitor in Resea

  2026-06-10

  Oseltamivir acid stands out as a robust influenza neuraminidase inhibitor, uniquely enabling both precise viral inhibition studies and innovative oncology workflows. This article unpacks applied use-cases, optimized experimental designs, and troubleshooting strategies to maximize reproducibility and translational potential in influenza antiviral research.

• Phillygenin Attenuates Diabetic Nephropathy via Inflammation

  2026-06-10

  This study demonstrates that phillygenin, a Forsythia suspensa-derived compound, ameliorates diabetic nephropathy by targeting inflammation and apoptosis through TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling. The findings highlight novel mechanistic insights and translational potential for cell-based and in vivo models of diabetic kidney injury.

• ETS1 Regulates SUMOylation-Dependent Mitophagy in BPD Models

  2026-06-09

  This study uncovers a mechanistic link between the transcription factor ETS1 and the SENP2/HSPA8/FUNDC1 axis, demonstrating how ETS1 suppresses mitochondrial damage-induced autophagy in bronchopulmonary dysplasia (BPD) by modulating sumoylation. These insights highlight ETS1 as a pivotal regulator of mitochondrial quality control and suggest new molecular targets for neonatal lung disease intervention.

• Improved In Vitro Metrics Refine Drug Response in Cancer Res

  2026-06-09

  Schwartz (2022) introduces a refined framework for evaluating anti-cancer drug responses by distinguishing relative viability from fractional viability in in vitro assays. This approach clarifies the balance between proliferation inhibition and cell death, enhancing the precision of drug effect interpretation and guiding the development of targeted agents such as p53 pathway modulators.

• AI-10-49: Deep Mechanistic and Translational Advances in inv

  2026-06-08

  Explore the mechanistic and translational impact of AI-10-49, a selective CBFβ-SMMHC inhibitor, in acute myeloid leukemia research. This in-depth article unveils how AI-10-49 uniquely clarifies the N-MYC/eIF4G1 axis and informs the design of next-generation leukemia assays.

• Comparative Antibacterial Efficacy of N-Formimidoyl Thienamy

  2026-06-08

  This article examines the landmark comparative study of N-formimidoyl thienamycin (MK0787) against a suite of recently developed β-lactam antibiotics, focusing on activity against multidrug-resistant clinical isolates. The findings inform both mechanistic understanding and practical assay design for antibiotic resistance research.

443 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page